SCARA5 and urinary bladder carcinoma: Consistent with the results, Shu -Cheng Liu et al. revealed BMSC-derived exosomal PTENP1 suppressed the bladder cancer by upregulating the expression of SCARA5, making it a potential target for bladder cancer therapy [75].